Nivolumab and olaparib

Dominic A. Solimando, James Waddell

Research output: Contribution to journalArticle

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)356-366
Number of pages11
JournalHospital Pharmacy
Volume50
Issue number5
DOIs
StatePublished - Jan 1 2015

Fingerprint

Poisons
Pharmacists
Antineoplastic Agents
Drug Therapy
Chemotherapy
Neoplasms
Therapeutics
nivolumab
olaparib

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Nivolumab and olaparib. / Solimando, Dominic A.; Waddell, James.

In: Hospital Pharmacy, Vol. 50, No. 5, 01.01.2015, p. 356-366.

Research output: Contribution to journalArticle

Solimando, Dominic A. ; Waddell, James. / Nivolumab and olaparib. In: Hospital Pharmacy. 2015 ; Vol. 50, No. 5. pp. 356-366.
@article{8fccc32436ff4c71971f0b800cdd8f98,
title = "Nivolumab and olaparib",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Solimando, {Dominic A.} and James Waddell",
year = "2015",
month = "1",
day = "1",
doi = "10.1310/hpj5005-356",
language = "English (US)",
volume = "50",
pages = "356--366",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "5",

}

TY - JOUR

T1 - Nivolumab and olaparib

AU - Solimando, Dominic A.

AU - Waddell, James

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=84975722447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975722447&partnerID=8YFLogxK

U2 - 10.1310/hpj5005-356

DO - 10.1310/hpj5005-356

M3 - Article

VL - 50

SP - 356

EP - 366

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 5

ER -